If you have any kind of money in the stock market, read this ASAP



Daily Market Alert



Friday, August 7, 2026 • Daily Market Alert

You are receiving this email because you are subscribed to Daily Market Alert,
a publication from Behind the Markets.
If you no longer wish to receive these sponsored emails, please unsubscribe
here
<[link removed]>
.




Sponsored Content




Dear Reader,



WSJ says, "It's the $64 trillion question—will there be a stock market crash
soon?" …



<[link removed]>



Weiss Ratings' research shows the first half of 2026 could be very tough for
not all, but certain stocks <[link removed]>...



Specifically, a radical shift is about to hit the market …



And it could send some of America's most popular stocks crashing down.



We've identified five stocks you should absolutely avoid as this event plays
out <[link removed]> …



You'll want to see this list …



And make sure you don't own any of these stocks before the market opens
tomorrow …



Because if you hold on to them — it could mean financial ruin.



To find out more about this incoming market shift …



Including the list of five stocks you must absolutely avoid …



Click here now — before it's too late <[link removed]>.



Sincerely,



Eliza Lasky,
Weiss Advocate

Full Details > <[link removed]>

 


Additional Reading from Daily Market Alerts:

Five Strong Buy Stocks to Watch for Friday, August 7

Analyst upgrades kept flowing on Thursday, August 6, with JP Morgan making a
bold Overweight call on Charles River and lifting its target to $310 from $180,
Argus turning bullish on Roper Technologies, Wolfe Research raising Global
Payments, Jefferies flipping J&J Snack Foods to Buy, and TD Cowen upgrading
TPG. The July 29 FOMC held rates at 3.50%-3.75%, and CME Group's FedWatch tool
still assigns roughly an 80% probability to no cuts through 2026. The five
names below span life sciences, consumer staples, payments, industrial
technology, and alternative asset management.

Charles River Laboratories (CRL) — JP Morgan turns bold on a biotech-funding
comeback

Charles River is a global contract research organization providing
preclinical drug discovery, safety assessment (DSA), research models, and
manufacturing services to biotech and pharma. On August 6, JP Morgan analyst
Casey Woodring upgraded from Neutral to Overweight with a $310 target (up from
$180), citing a biotech-funding rebound flowing into DSA bookings. The upgrade
followed the August 5 Q2 print: organic revenue up 0.1% (versus prior guidance
for a low-single-digit decline), a 420 bp sequential operating-margin
improvement to 20.5%, and raised full-year non-GAAP EPS guidance of
$11.15-$11.45. Evercore ISI's Ross Muken raised his Outperform target to $300
from $260, and RBC Capital's Ryan Halsted raised his Outperform target to $282
from $215.

Shares traded at $258.79 on August 6, down 0.74%, with a market cap of $12.5
billion. The 52-week range is $144.26 to $267.74. The consensus rating is
Strong Buy, with 9 of 12 covering analysts bullish, an average target of
$240.83, a median of $232.50, a high of $310, and a low of $175.

Risks: The stock has already run more than 75% off its 52-week low,
tightening the risk-reward; DSA-book conversion remains sensitive to
biotech-funding cycles; and reported GAAP Q2 results included a net loss on
impairment charges. Mizuho's Ann Hynes maintains Neutral with a $175 target.

J&J Snack Foods (JJSF) — Jefferies upgrades on Project Apollo margin engine

J&J Snack Foods is a specialty branded snack company (SUPERPRETZEL, Icee,
Dogsters, Luigi's) selling into retail, foodservice, and frozen beverage
channels. On August 6, Jefferies analyst Scott Marks upgraded from Hold to Buy
with a $101 target (up from $81), citing Project Apollo's expanding margin
contribution. The August 5 fiscal Q3 print: adjusted EPS of $1.96 versus
$1.70-$1.80 consensus, revenue of $426 million (down 6.2% YoY), gross margin
expanding 240 bp to 35.5%, and management raising annualized
plant-consolidation savings to at least $20 million from $15 million.

Shares traded at $91.45 on August 6, up 8.02%, with a market cap of $1.7
billion and a trailing P/E of 35.34. The 52-week range is $68.87 to $116.32.
The consensus is Strong Buy, with both covering analysts bullish, an average
target of $110.50, a high of $120, and a low of $101.

Risks: Revenue is still declining year-over-year and Q3 missed the top line;
retail volumes remain sensitive to slotting-fee investment and snack
innovation; and coverage is thin, producing sharper reactions to individual
moves. Benchmark's Todd Brooks cut his Buy target to $120 from $130 earlier
this year.

Global Payments (GPN) — Wolfe Research flips to Outperform on post-close
Worldpay setup

Global Payments provides payment technology and software services to
merchants and financial institutions worldwide, and completed its Worldpay
acquisition earlier this year. On August 6, Wolfe Research upgraded from Peer
Perform to Outperform with a $110 target, citing the Q2 print and integration
progress. The August 5 Q2 report: adjusted EPS of $3.46 (up 11.7% YoY, $0.02
ahead), adjusted net revenue of $3.16 billion (up ~4% normalized), and GAAP
revenue of $3.32 billion (up 68.6% YoY on Worldpay). Argus's Stephen Biggar
raised his Buy target to $110 from $95, and RBC's Daniel Perlin raised his
Sector Perform target to $96 from $82.

Shares traded at $86.33 on August 6, down 1.32%, with a market cap of $21.4
billion. The 52-week range is $61.16 to $90.64. The consensus rating is Buy,
with 6 of 16 covering analysts bullish, an average target of $92.25, a median
of $92, a high of $111, and a low of $74.

Risks: Adjusted net revenue growth remains mid-single digits despite
Worldpay; management flagged softer full-year revenue guidance and continued
Middle East pressure; and integration on a large acquisition can weigh on
near-term margins. Truist Securities' Matthew Coad maintains Hold with an $81
target.

Continue Reading →
<[link removed]>


11780 US Highway 1,
Palm Beach Gardens, FL 33408-3080

Copyright © 2026 Weiss Ratings. All rights reserved.



At Daily Market Alert <[link removed]>,
our priority is delivering insightful perspectives on the financial landscape
straight to our audience.The content above is an important message from one of
our highly valued sponsors.






This email is sent on behalf of Daily Market Alert, a Behind the Markets LLC
("the Company") publication, including its managers, employees, and assigns.
The Company does not provide any guarantee or warranty regarding the accuracy
or reliability of the information advertised herein.

The Company is not affiliated with any specific security mentioned in this
email, nor does it receive compensation from any such entity

Please be advised that the Company is not registered or licensed by any
governing body in any jurisdiction to offer investment advice or
recommendations.

None of the content in this email should be construed as personalized
financial advice. Any investment decisions made based on the information
provided should be done so only after consulting with a qualified investment
advisor and conducting a thorough review of the relevant prospectus or
financial statements

You are receiving this because you signed up for the Daily Market Alert
newsletter.

Daily Market Alert is a Behind the Markets <[link removed]>
Publication.

Behind the Markets, LLC

4260 NW 1st Ave #55, Boca Raton, FL.

Unsubscribe
<[link removed]>
Terms of Use <[link removed]> Privacy Policy
<[link removed]>